The Medicines for Human Use (Prescribing) Order 2005

Amendment of Schedule 3A to the POM Order

7.  In the table in Schedule 3A to the POM Order(1), (substances which may be prescribed, administered or directed for administration by extended formulary nurse prescribers)—

(a) in column 1 insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, the entry set out in column 1 below, and in column 2, insert, against that entry, the corresponding entry in column 2 below—

Column 1	Column 2
Acetylcysteine	Parenteral
Adrenaline	Parenteral
Alteplase	Parenteral
Amiodarone	Parenteral
Bemiparin sodium	Parenteral
Benzatropine mesilate	Parenteral
Calcipotriol	External
Calcitriol	External
Cefotaxime sodium	Parenteral
Ceftriaxone Sodium	Parenteral
Certoparin sodium	Parenteral
Chlorphenamine maleate	Parenteral
Cimetidine	Parenteral
Cyclizine hydrochloride	Oral
Cyclizine lactate	Parenteral
Dalteparin sodicum	Parenteral
Dexamethasone sodium phosphate	Oral
Dextran 70	Parenteral
Dolesetron mesilate	Oral and parenteral
Enoxaparin	Parenteral
Furosemide	Oral and parenteral
Gelatin 3.5 – 4%	Parenteral
Glucose 5%	Parenteral
Glucose 5% with Potassium (K+ 40 mmol/L) ready made infusion bag	Parenteral
Granisetron hydrochloride	Parenteral
Heparin sodium	Parenteral for the purpose of cannulae flushing
Hexastarch	Parenteral
Human soluble insulin	Parenteral
Hydroxyethl starch	Parenteral
Levomepromazine	Oral and parenteral
Naloxone	Parenteral
Omeprazole	Oral
Omeprazole sodium	Parenteral
Ondansetron Hydrochloride	Oral and parenteral
Oxbuprocaine hydrochloride	Ophalmic
Pentastarch	Parenteral
Prilocaine	External and parenteral
Prochlorperazine mesilate	Oral and rectal
Prochlorperazine maleate	Oral, rectal and buccal
Proxymetacaine hydrochloride	Ophthalmic
Reteplase	Parenteral
Sodium chloride 0.9%	Parental, for reconstitution of injections and for the purpose of cannulae flushing
Sodium chloride 0.9% & Glucose 5% ready made infusion bag	Parenteral
Sodium chloride 0.45% & Glucose 5% ready made infusion bag	Parenteral
Sodium chloride 0.9% with Potassium (K+ 40 mmol/L) ready made infusion bag	Parenteral
Sodium chloride 0.45% and Glucose 5% with Potassium 20mmol per 500 ml ready made infusion bag	Parenteral
Streptokinase	Parenteral
Tacalcitol	External
Tenecteplase	Parenteral
Tetanus immunoglobulin	Parenteral
Tetracaine	External
Tinzaparin sodium	Parenteral
Tropicamide	Ophthalmic
Tropisetron hydrochloride	Parenteral
Unfractionated Heparin	Parenteral
Vaccine – Combined Tetanus, diphtheria, acullular pertussis, inactivated poliomyelitis and haemophilus influenza type B	Parenteral
Vaccine – Inactivated Poliomyelitis	Parenteral
Vaccine – Meningococcal Polysaccharide A, C, W135 and Y	Parenteral

(b) in the entry for “Beclometasone dipropionate”, in column 2, after “nasal” add “inhalation”;

(c) in the entry for “Budesonide”, in column 2, after “Nasal” add “inhalation”;

(d) omit the entry for “Cyclizine”;

(e) in the entry for “Diazepam”(2), in column 2, omit “in palliative care”;

(f) in the entry for “Diclofenac sodium”(3), in column 2, after “oral” omit “or” and after “rectal” add “or ophthalmic”;

(g) in the entry for “Domperidone”, in column 2, omit “in palliative care”;

(h) in the entry for “Domperidone maleate”, in column 2, omit “in palliative care”;

(i) in the entry for “Flucloxacillin sodium”, in column 2, after “oral” add “or parenteral”;

(j) in the entry for “Hydrocortisone sodium succinate”, in column 2, after “lozenges” add “or parenteral”;

(k) in the entry for “Ipratropium bromide”, in column 2, after “nasal” add “inhalation”;

(l) in the entry for “Lorazepam”(4), in column 2, omit “in palliative care”;

(m) in the entry for “metoclopramide hydrochloride”, in column 2, omit “in palliative care”;

(n) in the entry for “Midazolam”(5), in column 2, omit “in palliative care”;

(o) in the entry for “Ranitidine hydrochloride”, in column 2, after “Oral” insert “or parenteral”.

(1)

Schedule 3A was inserted by S.I. 2002/549, and amended by S.I. 2003/696 and 2915, and 2004/2, 1189 and 2693.

(2)

The entry for “Diazepam” was inserted by S.I. 2003/2915.

(3)

The entry for “Diclofenac Sodium” was inserted by S.I. 2004/2.

(4)

The entry for “Lorazepam” was inserted by S.I. 2003/2915.

(5)

The entry for “Midazolam” was inserted by S.I. 2003/2915.